Lippoldt Darin bought NBIX
December 8, 2025 · Form 4 insider transaction
Lippoldt Darin bought 4,376 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $189.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,376
Price
$43.24
Total value
$189.2K
InsiderLippoldt Darin
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after47,781
OwnershipDirect
10b5-1 planNo
AmendedNo